ACIX.F Stock Overview
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Acarix AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.027 |
| 52 Week High | kr0.04 |
| 52 Week Low | kr0.014 |
| Beta | 1.38 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -23.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| ACIX.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.0% |
| 1Y | n/a | -1.4% | 21.9% |
Return vs Industry: Insufficient data to determine how ACIX.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how ACIX.F performed against the US Market.
Price Volatility
| ACIX.F volatility | |
|---|---|
| ACIX.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ACIX.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ACIX.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 20 | Aamir Mahmood | www.acarix.com |
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally. It offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced AI to analyze the patient's coronary blood flow. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Acarix AB (publ) Fundamentals Summary
| ACIX.F fundamental statistics | |
|---|---|
| Market cap | US$16.89m |
| Earnings (TTM) | -US$7.14m |
| Revenue (TTM) | US$572.21k |
29.8x
P/S Ratio-2.4x
P/E RatioIs ACIX.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACIX.F income statement (TTM) | |
|---|---|
| Revenue | kr6.24m |
| Cost of Revenue | kr944.00k |
| Gross Profit | kr5.30m |
| Other Expenses | kr83.14m |
| Earnings | -kr77.84m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | -0.098 |
| Gross Margin | 84.87% |
| Net Profit Margin | -1,247.22% |
| Debt/Equity Ratio | 0% |
How did ACIX.F perform over the long term?
See historical performance and comparison